Congratulations to Dr. Bryan Gardam on completing his PhD in our group! 🎉 We thank Bryan for his outstanding contributions over the past four years and wish him every success in his future endeavours.

Proud to see our collaboration with Prof. Chunxia Zhao’s lab at Adelaide University published! Our research uses mRNA lipid nanoparticles to boost anti-cancer immunity and suppress tumour growth in preclinical models. Read more: science.org/doi/10.1126/scia…

Our latest paper, led by PhD graduate Bryan Gardam, finds a severe decline in dendritic cells in brain tumours, potentially linked to tumour location and steroid treatment. Funded by @KidsCancerProj & Cancer Australia.

Last week, our lab attended the International Vascular Biology Meeting in Adelaide! @lisamebert presented her work, while Jasmine, Resty & Rachael presented theirs. Congratulations to our PhD students on receiving @AVBS_org travel bursaries! 🫀🧬

3 days, 2 conferences (COGNO & ABCARA), and a wealth of collaboration! 🧠 Our team presented research at COGNO & ABCARA 2026, with PhD students, ECRs, and Dr Tessa Gargett sharing insights. Together, we’re advancing precision care for brain cancer!

Every 3–4 months, we meet with Consumer Advocates—cancer survivors and bereaved families—to share research and clinical trial updates and seek their feedback. We’re grateful for their invaluable insights and support.

A quick rewind to one of our lab’s yearly traditions! 🧬 We had a fantastic time at the ASI SA–NT Branch Meeting 2026 in Victor Harbor, learning from fellow students and inspiring keynote speakers, while celebrating our lab members who presented their research! 🔬✨

Several members of our lab attended ISCT ANZ 2026 at the Melbourne Convention & Exhibition Centre, where global experts shared advances in cell and gene therapy, regenerative medicine and immunotherapy. Congratulations to Dr. Katie Williams on winning the Best Poster Award!

At the Translational Oncology Laboratory, we develop CAR-T cell therapies for aggressive cancers including glioblastoma, diffuse midline glioma, and melanoma. Partnering with hospitals, researchers, and industry across Australia, we aim to rapidly improve patient outcomes.